With a more favourable environment, KYORIN HOLDINGS INCO. improves to Positive
KYORIN HOLDINGS INCO. (JP), a company active in the Pharmaceuticals industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 7, 2020, the closing price was JPY 2,197.00 and its potential was estimated at JPY 2,373.81.KYORIN Holdings is a holding company mainly engaged in the manufacture and sale of pharmaceuticals. Co.'s principal two business segments are as follows. Ethical Pharmaceuticals segment is engaged in the manufacture, purchase and sale of pharmaceutical products; the evaluation of technologies; the inspection, analysis and negotiation of license affiliations; the manufacture of clinical testing products; and the research of new drugs and candidate compounds. Consumer Healthcare segment is involved in the development and sale of cosmetics and raw materials of medicines and cosmetics, the promotion of sales, the planning and production of advertisements, and the sale of packaging materials.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.